Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Recruiting 19Active not recruiting 13Completed 8Withdrawn 4Unknown 4Terminated 4Not yet recruiting 3

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Gynecologic 2

Conditions

Ovarian Neoplasms 1Mesothelioma, Malignant 1Mesothelioma 1Lung Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Unknown × dostarlimab × Clear all
NCT03016338 2024-01-30

Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer

University Health Network, Toronto

Phase 2 Unknown
51 enrolled
Gynecologic

Endometrial Neoplasms

NCT05065021 2024-01-17

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

University Health Network, Toronto

Phase 2 Unknown
40 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04940637 2023-05-12

UNITO-001

University of Turin, Italy

Phase 2 Unknown
70 enrolled
Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown
186 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡